DK0971735T3 - Fremgangsmåder og præparater til behandling af inflammatorisk tarmsygdom - Google Patents

Fremgangsmåder og præparater til behandling af inflammatorisk tarmsygdom

Info

Publication number
DK0971735T3
DK0971735T3 DK98912149T DK98912149T DK0971735T3 DK 0971735 T3 DK0971735 T3 DK 0971735T3 DK 98912149 T DK98912149 T DK 98912149T DK 98912149 T DK98912149 T DK 98912149T DK 0971735 T3 DK0971735 T3 DK 0971735T3
Authority
DK
Denmark
Prior art keywords
compositions
treatment
methods
inflammatory bowel
bowel disease
Prior art date
Application number
DK98912149T
Other languages
English (en)
Inventor
Thomas Julius Borody
Original Assignee
Borody Thomas J
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AUPO5940A external-priority patent/AUPO594097A0/en
Priority claimed from AUPO9785A external-priority patent/AUPO978597A0/en
Application filed by Borody Thomas J filed Critical Borody Thomas J
Application granted granted Critical
Publication of DK0971735T3 publication Critical patent/DK0971735T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/04—Mycobacterium, e.g. Mycobacterium tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DK98912149T 1997-04-01 1998-04-01 Fremgangsmåder og præparater til behandling af inflammatorisk tarmsygdom DK0971735T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AUPO5940A AUPO594097A0 (en) 1997-04-01 1997-04-01 Novel methods of treating inflammatory bowel disease
AUPO9785A AUPO978597A0 (en) 1997-10-14 1997-10-14 Methods of treating inflammatory bowel disease
PCT/AU1998/000222 WO1998043667A1 (en) 1997-04-01 1998-04-01 Methods and compositions for treating inflammatory bowel disease

Publications (1)

Publication Number Publication Date
DK0971735T3 true DK0971735T3 (da) 2008-07-07

Family

ID=25645389

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98912149T DK0971735T3 (da) 1997-04-01 1998-04-01 Fremgangsmåder og præparater til behandling af inflammatorisk tarmsygdom

Country Status (16)

Country Link
US (1) US6277836B1 (da)
EP (1) EP0971735B1 (da)
JP (3) JP2001524951A (da)
AR (1) AR012304A1 (da)
AT (1) ATE389417T1 (da)
CA (1) CA2285923C (da)
CY (1) CY1109783T1 (da)
DE (1) DE69839261T2 (da)
DK (1) DK0971735T3 (da)
ES (1) ES2303351T3 (da)
IL (1) IL132145A (da)
NO (1) NO325947B1 (da)
NZ (1) NZ500696A (da)
PT (1) PT971735E (da)
SI (1) SI0971735T1 (da)
WO (1) WO1998043667A1 (da)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6551632B2 (en) * 1997-04-01 2003-04-22 Thomas Julius Borody Methods and compositions for treating inflammatory bowel disease
AUPP325398A0 (en) 1998-04-30 1998-05-21 Borody, Thomas J. Improved method for eradicating h. pylori
WO2000047195A1 (en) * 1999-02-12 2000-08-17 Washington University Stimulating neutrophil function to treat inflammatory bowel disease
AR025976A1 (es) * 1999-10-08 2002-12-26 Affinium Pharm Inc Inhibidores de fab i.
JP3369535B2 (ja) 1999-11-09 2003-01-20 松下電器産業株式会社 プラズマディスプレイ装置
US7638496B2 (en) 2000-02-15 2009-12-29 Valeant Pharmaceuticals North America Nucleoside analogs with carboxamidine modified monocyclic base
KR20030011797A (ko) * 2000-03-28 2003-02-11 바이오케미 게젤샤프트 엠베하 맛이 차폐된 과립형 입자
WO2002018324A2 (en) 2000-08-29 2002-03-07 Nobex Corporation Immunoregulatory compounds, derivatives thereof and their use
DE60230934D1 (de) * 2001-04-06 2009-03-05 Affinium Pharm Inc Fab-i-inhibitoren
US8048924B2 (en) 2001-08-29 2011-11-01 Biocon Limited Methods and compositions employing 4-aminophenylacetic acid compounds
US20030118329A1 (en) * 2001-12-21 2003-06-26 Pere Obrador Video indexing using high resolution still images
AUPS088702A0 (en) * 2002-03-04 2002-03-28 Borody, Thomas Julius Electrolyte purgative
DK1575951T3 (da) 2002-12-06 2014-09-15 Debiopharm Int Sa Heterocykliske forbindelser, fremgangsmåder til fremstilling deraf og deres anvendelse i terapi
JP4880448B2 (ja) 2003-03-17 2012-02-22 アフィナム ファーマシューティカルズ，インコーポレーテッド 複数の抗生物質を含む組成物、及びそれを用いる方法
US6930093B2 (en) * 2003-07-10 2005-08-16 Valeant Research & Development Use of ribofuranose derivatives against inflammatory bowel diseases
WO2005046567A2 (en) * 2003-09-10 2005-05-26 Meena Shelgaonkar Synergistic formulation of antioxidants and antimycobacterial agents: a method of making the same
US7417037B2 (en) 2004-01-20 2008-08-26 The Board Of Regents Of The University Of Oklahoma Compositions and methods of treatment for inflammatory diseases
EP2361620B1 (en) 2004-02-06 2016-04-06 PHARMATEL (R&D) PTY LIMITED as Trustee for the PHARMATEL (R & D) TRUST Use of aminosalicylates in diarrhoea-predominant irritable bowel syndrome
KR20130028807A (ko) * 2004-05-28 2013-03-19 샐릭스 파마슈티컬스 인코포레이티드 방사선 유발성 장염의 예방, 치료 및 개선 방법
CA2568914C (en) 2004-06-04 2013-09-24 Affinium Pharmaceuticals, Inc. Therapeutic agents, and methods of making and using the same
WO2006014549A2 (en) 2004-07-07 2006-02-09 Nobex Corporation Synthesis of azo bonded immunoregulatory compounds
MX2008002283A (es) * 2005-08-24 2008-09-08 Salix Pharmaceuticals Inc Formulaciones de balsalazida y elaboracion y uso de las mismas.
US7452872B2 (en) * 2005-08-24 2008-11-18 Salix Pharmaceuticals, Inc. Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives
US8921344B2 (en) * 2006-11-03 2014-12-30 Salix Pharmaceuticals, Inc. Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives
KR20080075027A (ko) * 2005-12-05 2008-08-13 아피늄 파마슈티컬스, 인크. Ｆａｂｉ 억제제 및 항박테리아제로서의헤테로시클릴아크릴아미드 화합물
CA2531261A1 (en) * 2005-12-21 2007-06-21 Institut Pasteur Control of intestinal inflammatory syndromes with a preparation of killed or non infectious bacteria
JP5468899B2 (ja) 2006-07-20 2014-04-09 アフィニウム ファーマシューティカルズ， インク． Ｆａｂｉインヒビターとしてのアクリルアミド誘導体
US8263613B2 (en) * 2007-02-16 2012-09-11 Affinium Pharmaceuticals, Inc. Salts, prodrugs and polymorphs of fab I inhibitors
US8436051B2 (en) 2007-06-08 2013-05-07 Aptalis Pharma Canada Inc. Mesalamine suppository
US8217083B2 (en) * 2007-06-08 2012-07-10 Aptalis Pharma Canada Inc. Mesalamine suppository
US7541384B2 (en) 2007-06-08 2009-06-02 Axcan Pharma Inc. Mesalamine suppository
US20090098088A1 (en) * 2007-10-10 2009-04-16 The Procter & Gamble Company Methods And Kits For The Treatment Of Diverticular Conditions
JP2011500552A (ja) * 2007-10-10 2011-01-06 ルピン・リミテッド 胃腸障害を処置するための医薬用組み合わせおよび組成物
US20090131343A1 (en) * 2007-11-15 2009-05-21 Ly Tam Phan Use of bridged macrolides or tylosin derivatives in treating inflammatory bowel diseases
JP5572872B2 (ja) 2008-02-08 2014-08-20 レッド ヒル バイオファーマ リミテッド 炎症性腸疾患を治療するための方法および組成物
AU2009243066A1 (en) * 2008-05-01 2009-11-05 The Procter & Gamble Company Methods and kits for the treatment of inflammatory bowel disorder conditions
WO2011044140A1 (en) * 2009-10-05 2011-04-14 Catabasis Pharmaceuticals, Inc. Substituted thioacetic acid salicylate derivatives and their uses
WO2011050397A1 (en) 2009-10-26 2011-05-05 Borody Thomas J Novel enteric combination therapy
BR122014009845A2 (pt) 2010-04-26 2015-12-29 Salix Pharmaceuticals Ltd usos de balsalazida para preparação de composição farmacêutica para tratamento de distúrbio gastrointestinal e induzir remissão clínica de colite ulcerativa em indivíduos do sexo masculino, bem como para diminuir o escore de mmdai e cicatrização da mucosa em indivíduos do sexo masculino com colite ulcerativa
CN110200954A (zh) 2010-12-13 2019-09-06 萨利克斯药品有限公司 胃和结肠的配制剂及其制备和使用方法
TWI573590B (zh) * 2011-09-20 2017-03-11 雷希爾生藥有限公司 治療自體免疫疾病之組成物及方法
EP2861608B8 (en) 2012-06-19 2019-06-19 Debiopharm International SA Prodrug derivatives of (e)-n-methyl-n-((3-methylbenzofuran-2-yl)methyl)-3-(7-oxo-5,6,7,8-tetrahydro-1,8-naphthyridin-3-yl)acrylamide
AU2013294737B2 (en) 2012-07-27 2018-05-24 Redhill Biopharma Ltd. Formulations and methods of manufacturing formulations for use in colonic evacuation
CN106535941A (zh) 2014-05-22 2017-03-22 约翰·托德·金斯特纳 使用紫外线血液辐照和抗生素的组合治疗疾病
JP6998881B2 (ja) 2016-02-26 2022-02-10 デビオファーム・インターナショナル・エス・アー 糖尿病性足感染症の処置のための医薬
MX2023000165A (es) 2020-06-30 2023-02-22 Redhill Biopharma Ltd Productos de combinacion de dosis fijas de tres antibioticos, regimen de dosificacion, metodos y kits para tratar infecciones micobacterianas pulmonares no tuberculosas.

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4440763A (en) * 1981-03-18 1984-04-03 Block Drug Company, Inc. Use of 4-aminosalicyclic acid as an anti-inflammatory agent
GB8919321D0 (en) * 1989-08-25 1989-10-11 Univ London Treatment of chronic inflammatory conditions

Also Published As

Publication number Publication date
CA2285923A1 (en) 1998-10-08
DE69839261T2 (de) 2009-03-26
WO1998043667A1 (en) 1998-10-08
JP2008024713A (ja) 2008-02-07
US6277836B1 (en) 2001-08-21
SI0971735T1 (sl) 2008-08-31
IL132145A (en) 2005-11-20
EP0971735B1 (en) 2008-03-19
JP2012126736A (ja) 2012-07-05
PT971735E (pt) 2008-06-02
CA2285923C (en) 2013-03-12
CY1109783T1 (el) 2013-09-04
NO994778D0 (no) 1999-09-30
EP0971735A4 (en) 2004-02-25
JP2001524951A (ja) 2001-12-04
NO325947B1 (no) 2008-08-25
DE69839261D1 (de) 2008-04-30
ES2303351T3 (es) 2008-08-01
AR012304A1 (es) 2000-10-18
IL132145A0 (en) 2001-03-19
NO994778L (no) 1999-11-30
EP0971735A1 (en) 2000-01-19
NZ500696A (en) 2002-05-31
ATE389417T1 (de) 2008-04-15

Similar Documents

Publication Publication Date Title
DK0971735T3 (da) Fremgangsmåder og præparater til behandling af inflammatorisk tarmsygdom
DK1003479T3 (da) Fremgangsmåde og sammensætninger til behandling af allergiske senfasereaktioner og inflammatoriske sygdomme
DK1148875T3 (da) Fremgangsmåder og sammensætninger til forögelse af antallet af hvide blodlegemer
DK1109453T3 (da) Sammensætninger og fremgangsmåder til behandling af mitokondrielle sygdomme
ATE241977T1 (de) Verwendung von anti-mikrotubuli mitteln zur behandlung von entzündlichen darmerkrankungen
DK0980240T3 (da) Sammensætninger med lang frigivelse og fremgangsmåde til fremstilling heraf
NO20012916D0 (no) Sammensetninger og fremgangsmåter for behandling av anorektale forstyrrelser
NO973048L (no) Elastiske brönnsementsammensetninger og fremgangsmåter
DK1813624T3 (da) Fremgangsmåder og sammensætninger til forebyggelse og behandling af anæmi
NO20000011D0 (no) Skumdempersammensetninger og fremgangsmåter
NO20013393D0 (no) Brönnsementeringsfremgangsmåter og sammensetninger
NO20011613L (no) Sammensetninger og fremgangsmåte for WT1-spesifikk immunterapi
NO20002849D0 (no) Sammensetninger og metoder for Õ indusere genekspersjon
DK1749534T3 (da) Anvendelse af parasitære biologiske midler til forebyggelse og kontrol af inflammatorisk tarmsygdom
KR970000230A (ko) 염증성 장 질환을 치료하기 위한 캅파-아편제 작용물질
DK0772443T3 (da) Prednisolonmetasulfobenzoat-præparat til behandling af inflammatorisk tarmsygdom
DK1150991T3 (da) Præparater til behandling af inflammatoriske reaktioner
NO985385D0 (no) Bitumensammensetninger og fremgangsmÕte for fremstilling derav
NO996090L (no) Forbedret foskefor og fremgangsmåte for anvendelse av dette
DK0790998T3 (da) Azo-derivater af 5-aminosalicylsyre til behandling af inflammatorisk tarmsygdom
DE69815542D1 (de) Synergitische herbizide verfahren und zusammensetzungen
NO20010464D0 (no) Fremgangsmåter og sammensetninger for behandling av gastroösofrageal-reflukssyndrom
DK1140952T3 (da) Phosphororganiske forbindelser og anvendelse heraf
DK0905128T3 (da) Fremgangsmåder og mellemprodukter egnede til fremstilling af antifolater
NO20005223D0 (no) Sammensetning for og behandling av inflammatrisk tarmsykdom ved administrering av N-acetylglucosamin i tykktarmen